focus -WSS

focus

author：comprehensive 2025-10-01 04:45:02 - browse：52

Golden brain and DNA spiral illustration. -- biotech coverage from STAT — Adobe

The dream of being able to pluck a cell therapy off of a freezer shelf and speedily give it to cancer patients is materializing in the cancer world. Now, a new biotech hopes to do the same for patients with neurological conditions.

Kenai Therapeutics closed a $82 million Series A round Thursday co-led by Cure Ventures, The Column Group, and sovereign wealth fund Alaska Permanent Fund Corp. The San Diego-based biotech has big plans for that money — it’s already identified its lead drug candidate for people with Parkinson’s disease, and plans to move into a clinical trial within the next year.

Kenai — pronounced key-nigh — is developing therapies that use induced pluripotent stem cells, or iPSCs. These highly versatile organisms are derived from skin or blood cells and can be transformed into any type of cell. In Parkinson’s, the idea is that these cells would replace damaged neurons.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

hotspot

Wikipedia

WSS

Presidential fundraising highlights so far: Trump brings in more than DeSantis

HHS names first

Recent heat wave in the Mediterranean caused by climate change: Study

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

White House announces new plan to address the growing threat of xylazine in overdose crisis

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

hotspot

focus

hotspot

Supreme Court strikes down use of affirmative action

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Anesthesiologist group: stop taking Ozempic before surgery

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Hepatitis C has a cure — but many Americans still lack access to it

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

In age of alternative facts, a scholarly course on calling out crap

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

Dobbs anniversary: the lost opportunity of abortion as health care

Wisconsin governor employs partial veto to fund schools for 4 centuries

Wikipedia

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Pandemic and All Hazards Preparedness Act needs lean update

GSK to buy asthma

Wisconsin governor employs partial veto to fund schools for 4 centuries

Wikipedia

hotspot

Wikipedia

knowledge